Isabella C Glitza

Isabella C Glitza

UNVERIFIED PROFILE

Are you Isabella C Glitza?   Register this Author

Register author
Isabella C Glitza

Isabella C Glitza

Publications by authors named "Isabella C Glitza"

Are you Isabella C Glitza?   Register this Author

34Publications

1537Reads

20Profile Views

Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).

J Neurooncol 2019 May 7;142(3):499-509. Epub 2019 Mar 7.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03121-2DOI Listing
May 2019

Management of metastatic cutaneous melanoma: updates in clinical practice.

Ther Adv Med Oncol 2019 22;11:1758835919851663. Epub 2019 May 22.

Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, SP, Brazila and Department of Medical Oncology, A Beneficência Portuguesa de São Paulo - BP, São Paulo, SP, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758835919851663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535734PMC
May 2019

Leptomeningeal disease in uveal melanoma: a case series.

J Neurooncol 2018 Sep 27;139(2):503-505. Epub 2018 Apr 27.

The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 430, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-018-2878-5DOI Listing
September 2018

Phase I Dose-Escalation Study of Anti-CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced Cancers.

Mol Cancer Ther 2018 03 13;17(3):671-676. Epub 2017 Dec 13.

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-17-0673DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935561PMC
March 2018

Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases.

Melanoma Res 2017 12;27(6):580-584

Departments of aMelanoma Medical Oncology bDiagnostic Radiology cRadiation Oncology dNeurosurgery, The University of Texas MD Anderson Cancer eRadiation Oncology, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000389DOI Listing
December 2017

Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient.

J Neurooncol 2017 Jul 20;133(3):663-665. Epub 2017 May 20.

Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2472-2DOI Listing
July 2017

Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body Imagers.

Radiology 2017 05;283(2):314-340

From the Department of Radiology, Abdominal Imaging Section (V.L.C., P.B., N.W.B., A.Q.), Department of Gastrointestinal Medical Oncology (G.R.V.), Department of Melanoma Medical Oncology (I.C.G.), Department of Thoracic and Head & Neck Medical Oncology (K.A.G.), Department of Gynecologic Oncology (P.T.S.), Department of Investigational Cancer Therapeutics (J.T.A., D.S.H.), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017152224DOI Listing
May 2017

Chromosome 8q24.1/c-MYC abnormality: a marker for high-risk myeloma.

Leuk Lymphoma 2015 Mar 18;56(3):602-7. Epub 2014 Aug 18.

Hematology/Oncology Fellowship, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center , Houston, TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.924116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333105PMC
March 2015

Genotyping of cutaneous melanoma.

Chin Clin Oncol 2014 Sep;3(3):27

Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2014.03.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306428PMC
September 2014